Julin Clara, Nielsen Signe Ledou, Grantzau Trine Lønbo, Ahmad Syed Azhar, Cowland Jack Bernard, Bonde Jesper, Nørgaard Peter
Department of Pathology, Amager and Hvidovre Hospital, Hvidovre, Denmark.
Department of Pathology, Herlev and Gentofte Hospital, Herlev, Denmark.
APMIS. 2025 Jan;133(1):e13486. doi: 10.1111/apm.13486. Epub 2024 Oct 28.
Clonal hematopoiesis is highly prevalent in elderly patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), and around 20% of BPDCN patients have an associated myeloid malignancy. We present a patient with localized BPDCN and concomitant myelodysplastic syndrome (MDS), previously followed for several years due to clonal cytopenia of unknown significance. Compared targeted next-generation sequencing (NGS) of the skin tumor and sequential bone marrow samples showed shared variants in ASXL1 and TET2 with a de novo NRAS variant in both BPDCN and MDS compared to preceding bone marrow samples. These findings illustrate a shared clonal origin of BPDCN and MDS resulting from progressive clonal hematopoiesis.
克隆性造血在老年母细胞样浆细胞样树突状细胞肿瘤(BPDCN)患者中非常普遍,约20%的BPDCN患者伴有髓系恶性肿瘤。我们报告了一名局限性BPDCN并伴有骨髓增生异常综合征(MDS)的患者,该患者此前因意义未明的克隆性血细胞减少症已随访数年。对皮肤肿瘤和连续骨髓样本进行的靶向二代测序(NGS)显示,与之前的骨髓样本相比,ASXL1和TET2存在共享变异,且BPDCN和MDS中均有一个新发NRAS变异。这些发现说明了BPDCN和MDS源于进行性克隆性造血的共同克隆起源。